DGA Diet Patterns for Obesity
(DGA4ME Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different diet patterns affect weight loss and heart health. Researchers compare a Mediterranean-style diet, which follows the Dietary Guidelines for Americans and emphasizes fruits, vegetables, and whole grains, to a typical American diet (TAD diet pattern). They aim to determine if losing weight with this healthier diet improves heart health more than simply maintaining weight. Suitable participants have a Body Mass Index (BMI) between 23-39.9 or a body fat percentage between 32-50%, along with indicators like slightly high blood sugar or blood pressure. As an unphased trial, this study provides a unique opportunity to contribute to understanding the impact of diet on health.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any medications for elevated lipids, elevated glucose, high blood pressure, weight loss, or conditions that require corticosteroids to participate in this study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the DGA Mediterranean diet offers significant health benefits. Studies have consistently found that people who follow this diet have a lower risk of heart problems. It is considered a healthy way of eating that can also aid in weight loss, especially with reduced calorie intake.
In contrast, the Typical American Diet (TAD) often includes many processed foods and sugars, linking it to higher risks of health issues like obesity and heart disease. However, this study modifies the TAD to include fewer calories, which might help reduce some of these risks.
Both diets in this trial involve consuming fewer calories, which can aid in weight loss and improve health. The study does not introduce new drugs or treatments, focusing solely on different eating habits. Therefore, safety concerns mainly involve adhering to healthy eating guidelines and ensuring safe food preparation.12345Why are researchers excited about this trial?
Researchers are excited about these diet patterns for obesity because they offer fresh perspectives on managing weight through tailored dietary approaches. The DGA Mediterranean diet pattern focuses on energy balance or a negative energy balance by emphasizing fruits, vegetables, and whole grains while limiting added sugars, saturated fats, and sodium. This contrasts with the Typical American Diet (TAD) pattern, which reduces calorie intake by about 25% while mimicking common American dietary habits. Unlike many standard weight-loss treatments that might focus on medication or surgery, these diet patterns promote sustainable lifestyle changes aligned with the Dietary Guidelines for Americans. The trial aims to uncover how these distinct dietary strategies can effectively combat obesity, offering potentially healthier and more accessible alternatives.
What evidence suggests that this trial's diet patterns could be effective for obesity?
Research has shown that following a Mediterranean diet, as recommended by the Dietary Guidelines for Americans (DGA), can help reduce the risk of obesity. This trial will test two variations of the DGA Mediterranean diet pattern: one focusing on energy balance and another on negative energy balance. The diet emphasizes fruits, vegetables, and whole grains while reducing added sugars and unhealthy fats. Studies have found that it may improve heart and metabolic health.
In contrast, the trial will also study the typical American diet (TAD) pattern, which is high in calories, fats, and salt, and is linked to weight gain and poor heart health. It often lacks important nutrients found in healthier diets. Compared to the Mediterranean diet, the TAD generally proves less effective in improving health related to obesity.12467Who Is on the Research Team?
Kevin D Laugero, PhD
Principal Investigator
USDA, Western Human Nutrition Research Center
Are You a Good Fit for This Trial?
This trial is for adults with obesity, defined as a BMI of 27-39.9 or body fat percentage of 32-50%. Participants should have certain cardiometabolic risk factors like elevated fasting glucose, triglycerides, blood pressure, or A1C levels. They must be willing to have blood drawn and not currently use dietary supplements, alcohol excessively, or caffeine on lab days. Those with recent serious medical conditions or surgeries that affect diet are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Controlled Feeding
Participants are assigned to one of three diet patterns for an 8-week controlled feeding period
Post-Diet Testing
Post-diet testing to assess changes in various health parameters
Follow-up
Participants receive dietary education and are observed for long-term effects
What Are the Treatments Tested in This Trial?
Interventions
- DGA Mediterranean diet pattern
- TAD diet pattern
DGA Mediterranean diet pattern is already approved in United States, European Union for the following indications:
- General health promotion
- Cardiometabolic risk reduction
- Weight management
- Cardiovascular health
- Type 2 diabetes prevention
- Obesity management
Find a Clinic Near You
Who Is Running the Clinical Trial?
USDA, Western Human Nutrition Research Center
Lead Sponsor